Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
-1.22%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$39.8B
AUM Growth
-$3.97B
(-9.1%)
Cap. Flow
-$3.14B
Cap. Flow
% of AUM
-7.88%
Top 10 Holdings %
Top 10 Hldgs %
10.96%
Holding
3,846
New
599
Increased
854
Reduced
696
Closed
741
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$321M |
| 2 |
Kroger
KR
|
+$256M |
| 3 |
Pinterest
PINS
|
+$207M |
| 4 |
AT&T
T
|
+$198M |
| 5 |
Chevron
CVX
|
+$190M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$443M |
| 2 |
Merck
MRK
|
+$443M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$289M |
| 4 |
Coca-Cola
KO
|
+$266M |
| 5 |
Eli Lilly
LLY
|
+$237M |
Sector Composition
| 1 | Financials | 21.85% |
| 2 | Technology | 18.52% |
| 3 | Healthcare | 17.68% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Consumer Staples | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
NetEase
NTES
$96.8B
| $551K | ﹤0.01% |
+7,300
| New | +$551K |
|
1977
Leap Therapeutics
LPTX
$12.4M
| $547K | ﹤0.01% |
62,238
-18,906
| -23% | -$166K |
|
1978
VEON
VEON
$3.71B
| $547K | ﹤0.01% |
67,986
| – | – |
|
1979
PROS Holdings
PRO
$699M
| $546K | ﹤0.01% |
+22,096
| New | +$546K |
|
1980
Advantage Solutions
ADV
$619M
| $541K | ﹤0.01% |
+254,011
| New | +$541K |
|
1981
Patterson-UTI
PTEN
$2.13B
| $541K | ﹤0.01% |
+46,300
| New | +$541K |
|
|
YI
1982
111 Inc
YI
$51.3M
| $539K | ﹤0.01% |
20,180
-697
| -3% | -$18.6K |
|
|
ACCD
1983
DELISTED
Accolade, Inc. Common Stock
ACCD
| $539K | ﹤0.01% |
47,184
+27,409
| +139% | +$313K |
|
1984
Jack Henry & Associates
JKHY
$11.7B
| $538K | ﹤0.01% |
+2,953
| New | +$538K |
|
1985
PMV Pharmaceuticals
PMVP
$65.2M
| $538K | ﹤0.01% |
+45,207
| New | +$538K |
|
|
ROCL
1986
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $538K | ﹤0.01% |
+53,910
| New | +$538K |
|
1987
Adtran
ADTN
$809M
| $533K | ﹤0.01% |
26,773
+14,546
| +119% | +$290K |
|
1988
Teradyne
TER
$17.9B
| $533K | ﹤0.01% |
+7,100
| New | +$533K |
|
1989
Domo
DOMO
$701M
| $529K | ﹤0.01% |
29,421
+14,488
| +97% | +$260K |
|
1990
Generac Holdings
GNRC
$10.8B
| $529K | ﹤0.01% |
2,973
-6,733
| -69% | -$1.2M |
|
|
CVLY
1991
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $529K | ﹤0.01% |
+28,092
| New | +$529K |
|
1992
iShares MSCI Australia ETF
EWA
$1.55B
| $528K | ﹤0.01% |
+26,922
| New | +$528K |
|
1993
Mammoth Energy Services
TUSK
$114M
| $528K | ﹤0.01% |
154,899
-54,333
| -26% | -$185K |
|
|
ATYR
1994
aTyr Pharma
ATYR
$591M
| $527K | ﹤0.01% |
175,910
+16,503
| +10% | +$49.4K |
|
1995
Gladstone Investment Corp
GAIN
$544M
| $525K | ﹤0.01% |
+43,344
| New | +$525K |
|
|
SBOW
1996
DELISTED
SilverBow Resources, Inc.
SBOW
| $525K | ﹤0.01% |
19,527
-1,919
| -9% | -$51.6K |
|
|
OPRA
1997
Opera Ltd
OPRA
$1.76B
| $524K | ﹤0.01% |
120,676
-3,000
| -2% | -$13K |
|
1998
Treace Medical Concepts
TMCI
$456M
| $524K | ﹤0.01% |
+23,707
| New | +$524K |
|
1999
Cullinan Oncology
CGEM
$386M
| $520K | ﹤0.01% |
40,576
-2,547
| -6% | -$32.6K |
|
2000
iShares Core Dividend Growth ETF
DGRO
$34.2B
| $520K | ﹤0.01% |
+11,700
| New | +$520K |
|